Package Leaflet:information for theuser
Campral 333 mg film-coated tablets
Acamprosate
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information:
5 Conservation of Campral
Campral is a medicine that acts on the brain. Its action is exerted on certain brain substances that are related to the onset of alcohol dependence.
After the period of alcohol detoxification, Campral is indicated to prevent relapse into alcohol consumption. Treatment with Campral should always be accompanied by psychotherapy to achieve maintenance of alcohol abstinence.
Do not take Campral:
Warnings and precautions
Consult your doctor or pharmacist before taking Campral
Using Campral with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Taking Campral with food, drinks, and alcohol
Administration of Campral with food may reduce its efficacy, so it is recommended to take it before meals.
Although no interactions between Campral and alcohol have been described, it is not recommended to take them together.
Pregnancy, breast-feeding, and fertility
Although no harmful effects have been demonstrated, there is not enough data on the use of Campral in pregnant women.
It is not known whether Campral is excreted in human breast milk; however, since it has been shown to be excreted in animals, Campral should not be used in breast-feeding women.
It is not known whether Campral may affect human fertility.
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
Campral has no influence on the ability to drive and use machines.
Campral contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is essentially "sodium-free".
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.
The recommended dose is:
Use in children and adolescents
The safety and efficacy of Campral in patients under 18 years have not been established, so its use is not recommended in this population.
Method of administration
The tablets are taken without chewing with some liquid.
The tablets should be taken before meals.
Duration of treatment
The recommended duration of treatment is 1 year.
If you take more Campral than you should
Consult your doctor or pharmacist immediately.
Depending on the amount of medicine you have taken, it may be necessary to interrupt treatment.
Acute overdose is usually mild. In reported cases, the only symptom that may be related to overdose is diarrhea.
No case of hypercalcemia (elevated calcium levels) due to overdose has been reported. However, if this happens, treatment should be symptomatic.
In case of overdose or accidental ingestion, consult the Toxicological Information Service. Phone: 91.562.04.20.
If you forget to take Campral
Do not take a double dose to make up for forgotten doses.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Adverse reactions, when they occur, are usually mild and transient.
The following side effects may occur during treatment with Campral:
Very common (may affect more than 1 in 10 people):diarrhea
Common (may affect up to 1 in 10 people):nausea, vomiting, abdominal pain, flatulence, itching, skin rash, chill, decreased libido (sexual desire), and impotence.
Uncommon (may affect up to 1 in 100 people):increased libido.
Very rare (may affect up to 1 in 10,000 people):urticaria, angioedema (swelling under the skin, mainly in the face and neck), anaphylactic reactions (severe generalized allergic reaction).
Not known (frequency cannot be estimated from the available data):vesiculo-bullous eruptions.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines and Health Products Agency (AEMPS) website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Campral
Appearance of the product and contents of the pack
Campral is presented in packs of 84 film-coated tablets, white, round, with the inscription 333.
Marketing authorization holder and manufacturer
Marketing authorization holder
Merck Santé s.a.s.
37, rue Saint Romain
69379 Lyon Cedex 08 – France
Manufacturer
MERCK SANTE S.A.S. CENTRO DE PRODUCCION DE SEMOY2 rue du Pressoir Vert (Semoy) - F-45400 - FranceMERCK S.L.Polígono Merck (Mollet del Vallés (Barcelona)) - 08100 - Spain
You can ask for more information about this medicine to the local representative of the marketing authorization holder:
Spain
Merck, S.L.
Tel: + 34 935.65.55.00
Date of last revision of this leaflet: April 2019
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of CAMPRAL 333 mg FILM-COATED TABLETS in October, 2025 is around 28.68 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.